Company intelligence / Profile preview
Insud Pharma
- Ownership
- Private
- Employees
- ~9000
- Development stage
- Commercial
Overview
Insud Pharma operates globally across the entire pharmaceutical value chain. It develops and manufactures active pharmaceutical ingredients (APIs), finished dosage forms (FDFs), branded pharmaceuticals for human and animal care as well as biopharmaceutical products. Its biotech arm mAbxience develops biosimilars and monoclonal antibodies that have reached commercialization in multiple markets. The company has a strong focus on innovation with significant investment in R&D.
- Therapeutic areas
- PulmonologyCardiovascularImmunologyDermatologyWomen's HealthOncologyNeurology
- Modalities
- Small moleculeMonoclonal antibodyBiologicVaccine
- Industry
- Biotech
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Insud Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Insud Pharma.